Which Product to Develop? Product Selection and the Importance of Early Strategic Design for Success

This webinar will benefit executives at Biotech and Pharmaceutical companies interested in growth through pipeline expansion or new products. With a change in indication, therapeutic area, dosage form, or other innovation, products developed via the US 505(b)(2) regulatory pathway gain the advantage of utilizing appropriate existing literature to meet safety and efficacy claims. But in order to be beneficial, 505(b)(2) product development must utilize an early heavy strategic approach to enable a lower cost, lower risk, and faster path to regulatory approval and market.